A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples